Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cremolini

Showing results (81-90 of 284) with videos related to

Pageof 29
Sort By:
Oncology|June 12, 2023
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative ChemotherapyIrene Pecora, Clara Ugolini, Riccardo Giannini, et al.
Cancers|April 25, 2020
The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled AnalysisFabio Gelsomino, Andrea Casadei-Gardini, Daniele Rossini, et al.
International Journal of Cancer|May 9, 2014
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancerMarta Schirripa, Chiara Cremolini, Fotios Loupakis, et al.
Nature Genetics|June 19, 2019
Quantitative evidence for early metastatic seeding in colorectal cancerZheng Hu, Jie Ding, Zhicheng Ma, et al.
Cancers|April 13, 2023
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical TrialsDavide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti, et al.
Journal of the National Cancer Institute|February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancerFotios Loupakis, Dongyun Yang, Linda Yau, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Critical Reviews in Oncology/Hematology|November 24, 2024
Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paperUmberto Malapelle, Valentina Angerilli, Rossana Intini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
Pageof 29

Showing results (81-90 of 284) with videos related to

Sort By:
Pageof 29
Oncology|June 12, 2023
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative ChemotherapyIrene Pecora, Clara Ugolini, Riccardo Giannini, et al.
Cancers|April 25, 2020
The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled AnalysisFabio Gelsomino, Andrea Casadei-Gardini, Daniele Rossini, et al.
International Journal of Cancer|May 9, 2014
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancerMarta Schirripa, Chiara Cremolini, Fotios Loupakis, et al.
Nature Genetics|June 19, 2019
Quantitative evidence for early metastatic seeding in colorectal cancerZheng Hu, Jie Ding, Zhicheng Ma, et al.
Cancers|April 13, 2023
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical TrialsDavide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti, et al.
Journal of the National Cancer Institute|February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancerFotios Loupakis, Dongyun Yang, Linda Yau, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Critical Reviews in Oncology/Hematology|November 24, 2024
Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paperUmberto Malapelle, Valentina Angerilli, Rossana Intini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
Pageof 29